These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7112521)

  • 1. Observations during the treatment with antithrombin-III concentrate of a case of a tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin.
    Jespersen J; Rasmussen NR; Toftgaard C
    Thromb Res; 1982 Jun; 26(6):457-62. PubMed ID: 7112521
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J; Rasmussen NR; Sidelmann J
    Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic shock syndrome.
    Wroblewski SS
    Am J Nurs; 1981 Jan; 81(1):82-5. PubMed ID: 6906125
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disordered hemostasis related to sepsis and SIRS].
    Riess H
    Internist (Berl); 1998 May; 39(5):479-84. PubMed ID: 9647982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy with antithrombin III in burned children--pilot study].
    Del Principe D; Pietrantoni R; Menichelli A; Siviero MC; Luzi F; Colucci C; Orsini D
    Haematologica; 1990; 75 Suppl 2():33-40. PubMed ID: 2387549
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
    Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
    Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R; Lefrant JY; de la Coussaye JE
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic use of antithrombin concentrate in sepsis.
    Balk R; Emerson T; Fourrier F; Kruse JA; Mammen EF; Schuster HP; Vinazzer H
    Semin Thromb Hemost; 1998; 24(2):183-94. PubMed ID: 9579641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antithrombin concentrate in stable diffuse intravascular coagulation. A case report.
    Haak HL; Stolk JC; Gratama JW; van Hulsteyn H; Briet E
    Acta Haematol; 1982; 68(1):28-33. PubMed ID: 6812353
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal proteolysis (DIC)--successful treatment with antithrombin III concentrate and a concentrate containing F XIII and native von Willebrand factor.
    Delshammar M; Lasson A; Nilsson IM; Ohlsson K; Wallmark A; Vernersson E
    J Intern Med; 1989 Jan; 225(1):21-7. PubMed ID: 2783958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.
    Mesters RM; Mannucci PM; Coppola R; Keller T; Ostermann H; Kienast J
    Blood; 1996 Aug; 88(3):881-6. PubMed ID: 8704245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy with antithrombin III concentrate].
    Vinazzer H
    Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of antithrombin III concentrates in disseminated intravascular coagulation].
    Aoki N; Matsuki K; Sakata Y
    Rinsho Ketsueki; 1982 Jun; 23(6):804-10. PubMed ID: 7176087
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmapheresis in severe septic shock with disseminated intravascular coagulation.
    Zilow EP; Selle B; Zilow G
    Beitr Infusionsther Transfusionsmed; 1994; 32():374-7. PubMed ID: 9422119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III concentrate as adjuvant in DIC treatment. A pilot study in 9 severely ill patients.
    Hellgren M; Javelin L; Hägnevik K; Blombäck M
    Thromb Res; 1984 Aug; 35(4):459-66. PubMed ID: 6484893
    [No Abstract]   [Full Text] [Related]  

  • 19. Current management of disseminated intravascular coagulation.
    Wheeler A; Rubenstein EB
    Oncology (Williston Park); 1994 Sep; 8(9):69-73; discussion 73-6, 79. PubMed ID: 7993725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of antithrombin III concentrates].
    Vinazzer H
    Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.